We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VCKA market cap is 1.41B. The company's latest EPS is USD -0.7332 and P/E is -1.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 38.03M | 10.58M | 12.58M | 10.12M |
| Operating Income | -657k | -50.63M | -25.47M | -22.81M | -38.81M |
| Net Income | -131k | -23.99M | -30.75M | -26.65M | -35.53M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 38.03M | 46.74M |
| Operating Income | -6k | -1.01M | -50.63M | -105.43M |
| Net Income | -6k | 783k | -23.36M | -114.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 101.46M | 86.53M | 86.05M | 126.46M | 80.53M |
| Total Liabilities | 12.17M | 50.29M | 74.98M | 116.05M | 243.2M |
| Total Equity | -12M | 36.24M | 11.08M | 10.42M | -162.67M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 199k | 139.92M | 86.53M | 101.31M |
| Total Liabilities | 180k | 9.24M | 50.29M | 274.25M |
| Total Equity | 19k | -8.7M | 36.24M | -172.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -1.94M | -21.26M | -7.74M | -21.22M | -15.32M |
| Investing | 38.78M | -2.07M | N/A | -8k | -163k |
| Financing | -37.32M | 21.17M | 10.63M | 54.17M | 15.28M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1,000 | -802k | -21.26M | -20.71M |
| Investing | N/A | -139.38M | -2.07M | -330k |
| Financing | 32k | 140.66M | 21.17M | 23.58M |
| Market Cap | 1.41B |
| Price to Earnings Ratio | -1.17 |
| Price to Sales Ratio | 2.87 |
| Price to Cash Ratio | 34.26 |
| Price to Book Ratio | -0.78 |
| Dividend Yield | - |
| Shares Outstanding | 155.94M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.18 (1.73%) |
| Company Name | Vickers Vantage Corporation I |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.scilexholding.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
